|

Eflornithine (DFMO) Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Also known as: Difluoromethylornithine

Pipeline

Phase 1/2: 1

Top Sponsors

  • Milton S. Hershey Medical Center1

Indications

  • DIPG Brain Tumor1
  • Embryonal Tumor With Multilayered Rosettes1
  • Atypical Teratoid/Rhabdoid Tumor1
  • Neuroblastoma1
  • Diffuse Intrinsic Pontine Glioma1

Birmingham, Alabama1 trial

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

University of Alabama/Children's of Alabama

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.